Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: re: ``Even if they split the profits of 200 Billion a year one hundred billion for PTSC is not bad,

re: ``Even if they split the profits of 200 Billion a year one hundred billion for PTSC is not bad,

posted on Jun 09, 2006 10:50AM
I`m basing my numbers (all conjecture of course) on around 10 - 15 settlements/License per year. Each at 25 million. Let`s say an average of 400M/ year. Divide that by 2 and you are looking at 200M.

If things fall into play that seems realistic to me. Of course I could be entirely wrong on this either way but that is my guess.

Share
New Message
Please login to post a reply